Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
Bhavnani SM, Hammel JP, Lakota EA, Trang M, Bader JC, Bulik CC, VanScoy BD, Rubino CM, Huband MD, Friedrich L, Steenbergen JN, Ambrose PG. Bhavnani SM, et al. Among authors: friedrich l. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0221321. doi: 10.1128/aac.02213-21. Epub 2023 Mar 22. Antimicrob Agents Chemother. 2023. PMID: 36946741 Free PMC article. Clinical Trial.
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia.
Trang M, Hammel JP, Lakota EA, Safir MC, Bhavnani SM, Friedrich L, Steenbergen JN, McGovern PC, Tzanis E, Rubino CM. Trang M, et al. Among authors: friedrich l. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0220121. doi: 10.1128/aac.02201-21. Epub 2022 Dec 19. Antimicrob Agents Chemother. 2023. PMID: 36533934 Free PMC article. No abstract available.
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics.
Trang M, Lakota EA, Safir MC, Bhavnani SM, Friedrich L, Steenbergen JN, McGovern PC, Tzanis E, Rubino CM. Trang M, et al. Among authors: friedrich l. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0239721. doi: 10.1128/aac.02397-21. Epub 2023 Mar 14. Antimicrob Agents Chemother. 2023. PMID: 36916956 Free PMC article.
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model.
VanScoy BD, Jones S, Conde H, Friedrich LV, Cotroneo N, Bhavnani SM, Ambrose PG. VanScoy BD, et al. Among authors: friedrich lv. Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0090822. doi: 10.1128/aac.00908-22. Epub 2023 Feb 9. Antimicrob Agents Chemother. 2023. PMID: 36757190 Free PMC article.
Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety.
Lennerz C, O'Connor M, Schaarschmidt C, Reents T, Bourier F, Telishevska M, Lengauer S, Popa M, Wimbauer K, Holmgren E, Thoma M, Spitzauer L, Bahlke F, Krafft H, Englert F, Knoll K, Friedrich L, Blazek P, Hessling G, Kolb C, Deisenhofer I, Kottmaier M. Lennerz C, et al. Among authors: friedrich l. J Interv Card Electrophysiol. 2024 May 22. doi: 10.1007/s10840-024-01758-2. Online ahead of print. J Interv Card Electrophysiol. 2024. PMID: 38775921
335 results